Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP7 | P55210 | 2/20 | 0.55 |
| ▸ | G6PD | P11413 | 1/20 | 0.55 |
| ▸ | CASP6 | P55212 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | TTR | P02766 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 3/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.46 |
| ▸ | MMP2 | P08253 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | MMP13 | P45452 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7707773 | 0.86 | G6PD (0.57) | CASP7G6PDCASP6ALOX15ALDH1A1 | |
| SCHEMBL9293432 | 0.86 | TTR (0.48) | CASP7G6PDCASP6ALOX15ALDH1A1 | |
| SCHEMBL3951462 | 0.85 | G6PD (0.60) | CASP7G6PDCASP6ALOX15ALDH1A1 | |
| SCHEMBL15641524 | 0.85 | TTR (0.47) | CASP7G6PDCASP6ALOX15ALDH1A1 | |
| SCHEMBL2893168 | 0.82 | MAPT (0.53) | ALDH1A1HSD17B10TTRTSHRMEN1 | |
| Hydrochloric Acid SCHEMBL11302390 | 0.81 | TTR (0.44) | CASP7G6PDCASP6ALOX15ALDH1A1 | |
| SCHEMBL599747 | 0.81 | TTR (0.59) | CASP6ALDH1A1HSD17B10TDP1TTR | |
| SCHEMBL6457388 | 0.80 | G6PD (0.55) | CASP7G6PDCASP6ALOX15ALDH1A1 | |
| SCHEMBL10589344 | 0.80 | HTR6 (0.55) | CASP7G6PDCASP6ALOX15ALDH1A1 | |
| SCHEMBL5490712 | 0.80 | CASP7 (0.50) | CASP7G6PDCASP6ALOX15ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101172958-A | N,N*-2(2substituted phenyl) derivant of - 4-methoxy-1,3-benzol diamide and use of the same | UNIV TIANJIN TECHNOLOGY (CN) | 2008-05-07 | — | — | CN | claimed |
| US-4391894-A | BASIC DYE REACTED WITH ORGANIC ACID DISSOLVED IN A PHOTOSENSITIVE DIAZO COMPOSITION | POLYCHROME CORPORATION (US) | 1983-07-05 | — | — | US | claimed |
| US-20260108989-A1 | FLUX AND SOLDER PASTE | SENJU METAL INDUSTRY CO (JP) | 2026-04-23 | — | — | US | disclosed |
| EP-4706873-A1 | FLUX AND SOLDER PASTE | Senju Metal Industry Co., Ltd. (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-12304008-B2 | Flux and method for producing assembly | SENJU METAL INDUSTRY CO., LTD. (JP) | 2025-05-20 | — | — | US | disclosed |
| US-20240326176-A1 | FLUX AND METHOD FOR PRODUCING ASSEMBLY | SENJU METAL INDUSTRY CO., LTD. (JP) | 2024-10-03 | — | — | US | disclosed |
| US-20240109889-A1 | DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT | C4 THERAPEUTICS, INC. (US) | 2024-04-04 | — | — | US | disclosed |
| US-11787802-B2 | Dihydrobenzimidazolones for medical treatment | C4 THERAPEUTICS, INC. (US) | 2023-10-17 | — | — | US | disclosed |
| US-20220289738-A1 | DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT | C4 THERAPEUTICS, INC. (US) | 2022-09-15 | — | — | US | disclosed |
| US-11254672-B2 | Dihydrobenzimidazolones for medical treatment | C4 THERAPEUTICS, INC. (US) | 2022-02-22 | — | — | US | disclosed |
| CN-113795554-A | Achromatic polarizing element, and achromatic polarizing plate and display device using same | 日本化药株式会社 | 2021-12-14 | — | — | CN | disclosed |
| US-4507236-A | Fibre-reactive dyes, containing both chloro and fluoro triazine radicals | CIBA-GEIGY CORPORATION (US) | 1985-03-26 | — | — | US | disclosed |
| US-4424153-A | ARYLAZO-AZO-METHINE | BASF AKTIENGESELLSCHAFT (DE) | 1984-01-03 | — | — | US | disclosed |
| US-4391894-A | BASIC DYE REACTED WITH ORGANIC ACID DISSOLVED IN A PHOTOSENSITIVE DIAZO COMPOSITION | POLYCHROME CORPORATION (US) | 1983-07-05 | — | — | US | disclosed |
| EP-0047427-B1 | 1:2-CHROMIUM COMPLEX DYESTUFFS CONTAINING SULFONIC-ACID GROUPS | BASF Aktiengesellschaft (DE) | 1983-05-18 | — | — | EP | disclosed |
| EP-0047427-A1 | 1:2-Chromium complex dyestuffs containing sulfonic-acid groups | BASF Aktiengesellschaft (DE) | 1982-03-17 | — | — | EP | disclosed |
| US-4193916-A | Sulfo- or carboxy-aryl amino sulfonyl phenyl azo hydroxpyridine heavy metal complex dyes | CIBA-GEIGY CORPORATION (US) | 1980-03-18 | — | — | US | disclosed |
| US-4156750-A | Method for fabricating covering materials from leather for the upholstery and cushions of furniture and covering materials produced by said method | LUETHY ERNST (CH) | 1979-05-29 | — | — | US | disclosed |
| US-4025479-A | Removal of sulfuric acid compounds | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-05-24 | — | — | US | disclosed |
| US-3954690-A | Removal of sulfuric acid compounds | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108989-A1 | FLUX AND SOLDER PASTE | GRIN1, ROS1, PRXL2A | CASP7 2690/4885G6PD 2517/4885CASP6 3040/4885 |
| US-20240109889-A1 | DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT | CRBN, CUL4A, ADRM1 | CASP7 3493/4885G6PD 2369/4885CASP6 3660/4885 |
| US-20220289738-A1 | DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT | CRBN, CUL4A, ADRM1 | CASP7 3493/4885G6PD 2369/4885CASP6 3660/4885 |
| US-11787802-B2 | Dihydrobenzimidazolones for medical treatment | CRBN, CUL4A, ADRM1 | CASP7 3493/4885G6PD 2369/4885CASP6 3660/4885 |
| US-11254672-B2 | Dihydrobenzimidazolones for medical treatment | CRBN, CUL4A, ADRM1 | CASP7 3493/4885G6PD 2369/4885CASP6 3660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.